Unlock instant, AI-driven research and patent intelligence for your innovation.

Duck hepatitis A virus VP1 protein gene and application thereof

A technology of duck hepatitis A virus and gene, applied in the direction of antiviral immunoglobulin, application, antiviral agent, etc., can solve the problems of inability to protect duck viral hepatitis diseases

Inactive Publication Date: 2015-04-22
杭州百裕生物科技有限公司
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Epidemiological surveys in recent years have shown that DHAV-3 continues to appear in my country and is often co-infected with DHAV-1, while duck viral hepatitis vaccines that have been approved for marketing in China (duck viral hepatitis attenuated strains A66 and CH60) All are DHAV-1 strains, which can no longer provide effective protection against the current domestic clinically complicated duck viral hepatitis disease.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Duck hepatitis A virus VP1 protein gene and application thereof
  • Duck hepatitis A virus VP1 protein gene and application thereof
  • Duck hepatitis A virus VP1 protein gene and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Embodiment 1 The acquisition of novel composite duck hepatitis A virus VP1 protein and its gene

[0016] 1. Carry out antigenicity analysis on the VP1 protein sequence of the representative strain of DHAV-1 (GenBank accession number: GU363950.1) and the VP1 protein sequence of the representative strain of DHAV-3 (GenBank accession number: EU289393.1), and select DHAV respectively -1 VP1 protein dominant epitope (94-146) is spliced ​​with DHAV-3 VP1 protein dominant epitope (115-223), and protein lingker (GGGSGGGS) is added in the middle to promote the correct folding of the two sequences, and finally The amino acid sequence of the obtained novel composite duck hepatitis A virus VP1 protein is SEQ ID NO:1.

[0017] 2. According to the obtained amino acid sequence SEQ ID NO: 1 of the novel composite duck hepatitis A virus VP1 protein, redesign according to the codon preference of the Escherichia coli gene, and obtain the nucleotide sequence SEQ ID NO: 2 encoding the compo...

Embodiment 2

[0018] The construction of embodiment 2 genetic engineering protein expression vector and the acquisition of engineering bacteria

[0019] 1. The VP1 gene protein gene BamH I and Hind III synthesized by the above-mentioned whole gene was double digested and then ligated into the corresponding restriction site of the pET28a vector to construct the pET28a / VP1 expression vector.

[0020] 2. Use CaCl 2 Transform the pET28a / VP1 expression vector into Escherichia coli BL21(DE3), spread it on an agar plate containing 50 μg / ml kanamycin, and culture overnight at 37°C. 10 single colonies were selected to extract plasmids, and the positive colonies verified by BamH I and Hind III double enzyme digestion were further sequenced and identified. The positive clones verified by sequencing were fermented and cultured in LB medium to 0.6-0.8 hours and induced by adding 0.5mM IPTG for 4-5 hours, and the bacteria were collected by centrifugation for SDS-PAGE electrophoresis, and uninduced bacte...

Embodiment 3

[0021] Example 3 Fermentation, purification and preparation of compound duck hepatitis A virus genetically engineered subunit vaccine

[0022] 1. Fermentation process

[0023] 1) LB medium as seed medium, containing 5g / L glucose and 5g / L MgSO 4 ·7H 2 The LB medium of O was used as the fermentation medium, and the feeding materials were glucose 400g / L, peptone 24g / L, yeast extract 10g / L, NaCl 5g / L, MgSO 4 ·7H 2 O 5g / L.

[0024] 2) Fermentation process

[0025] The identified engineered bacteria were picked and inoculated into LB medium containing kanamycin at a concentration of 50 μg / ml, and cultured with shaking at 37°C for 8 hours as the seed solution. The seed liquid is inoculated in the fermenter according to the inoculation amount of 5%, and all parameters are adjusted, 37°C, 200 rpm, and the dissolved oxygen is controlled above 20%. After 4.5 hours of fermentation, feed feeding was started, 0.5mmol / L IPTG was added after 6 hours of fermentation to induce expression,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention firstly provides a novel composite duck hepatitis A virus structural protein VP1. The amino acid sequence of the encoded protein of the novel composite duck hepatitis A virus structural protein VP1 is SEQ ID No.1; the structural protein VP1 is used as an antigen to prepare genetic engineering subunit vaccine of the composite duck hepatitis A virus. According to the invention, escherichia coli BL21(DE3) host bacteria capable of expressing the composite duck hepatitis A virus structural protein VP1 is created by a pET28a (+) expression vector. By SDS-PAGE analysis, 20kD recombinant target protein is expressed. The recombinant protein is purified and prepared into the genetic engineering subunit vaccine to immunize 4 months old ducks, after twice immunization, the hatched ducklings can obtain the immune protection of DHAV-1 and DHAV-3 strains.

Description

technical field [0001] The invention belongs to the technical field of functional gene modification, and in particular relates to a duck hepatitis A virus VP1 protein gene and application thereof. Background technique [0002] Duck hepatitis A virus (Duck hepatitis A virus, DHAV) mainly infects ducklings aged 1-3 weeks. It is a highly pathogenic and rapidly spreading viral disease of ducks, with a mortality rate of over 90%. It is distributed worldwide and brings great losses to the duck industry. Duck hepatitis A virus is mainly divided into three genotypes: A, B and C, corresponding to three serotypes DHAV-1, DHAV-2 and DHAV-3. DHAV-1 was first isolated from the United States in 1950. It is a classic strain and is currently distributed all over the world. It is the main strain currently prevalent in China. DHAV-3 is the first new strain isolated from South Korea. These three serotypes had no or only limited cross-protection against each other. [0003] Epidemiological ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K16/10C12N15/51C12N15/70A61K39/29A61P31/14
Inventor 王宏华
Owner 杭州百裕生物科技有限公司